Meat Consumption and Risk of Esophageal and Gastric Cancer in the Golestan Cohort Study, Iran Publisher Pubmed



Collatuzzo G¹ ; Etemadi A^{2, 3} ; Sotoudeh M³ ; Nikmanesh A³ ; Poustchi H³ ; Khoshnia M^{3, 4} ; Pourshams A³ ; Hashemian M^{3, 5} ; Roshandel G^{3, 4} ; Dawsey SM² ; Abnet CC² ; Kamangar F⁶ ; Brennan P⁷ ; Boffetta P^{1, 8} Show All Authors
Source: International Journal of Cancer Published:2022

Abstract

Red meat and processed meat are associated with some gastrointestinal cancers. Our study aims to investigate the association of different meat types with esophageal and gastric cancer (EC, GC) in a high-risk population. The Golestan Cohort Study (GCS) is a population-based cohort of 50 045 individuals aged 40 to 75 from northeast Iran. Detailed data on different exposures were collected using validated questionnaires. We considered quintiles of meat consumption, using grams and density (g/1000 kcal/day). We calculated intake of red, processed, organ and white meat, as well as total red meat, including the first three. We used proportional hazards regression models to estimate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for the association between meat types and cancer. During 12 years of follow-up, out of 49 585 participants (57.4% women), 369 developed EC (48.2% women) and 368 developed GC (27.5% women), including 309 esophageal squamous cell, 20 esophageal adenocarcinomas, 216 cardia and 95 non-cardia GC. No association was found for EC except for red meat among females (HR for one quintile increase 1.13, 95% CI = 1.00-1.27). The risk of GC increased for intake of total red meat (HR 1.08, 95% CI = 1.00-1.17) and red meat separately (HR 1.09, 95% CI = 1.00-1.18). The HR for red meat and non-cardia GC was 1.23 (95% CI = 1.02-1.48). No associations were observed for other types of meat. In conclusion, in this high-risk population red meat intake is associated with GC, but not EC, suggesting a substantial role of this modifiable factor in determining the burden of GC. © 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.